Browse All
Displaying 1 - 1 of 1
Author:Harris, Sarah Vermersch, Patrick Montalban, Xavier Hartung, Hans-Peter Kappos, Ludwig Southworth, Harry Sheffield, James K. Silva, Diego Cohen, Jeffrey A.
Session Name:P1: MS Biomarkers
Topic:MS and Inflammatory Disease
Program Number:P1.012
Author Institution:Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Univ. Lille, Inserm UMR U1172, CHU Lille, FHU Precise, Lille, France, Lille, France Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany Brain and Mind Centre, University of Sydney, Sydney, Australia Department of Neurology, Medical University of Vienna, Vienna, Austria and Palacký University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland Data Clarity Consulting Ltd, Stockport, England, United Kingdom, England, United Kingdom Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH
